[-] Show simple item record

dc.contributor.authorDuke, Timen_US
dc.contributor.authorMohundro, Brice L.en_US
dc.date.issued2009-12
dc.description.abstractHigh-dose statins are better at prolonging the time to the first cardiovascular event in patients with diabetes and chronic kidney disease, but not in patients with diabetes who have normal kidney function. (SOR B, based on a randomized controlled trial.) High-dose statin therapy reduces the risk of myocardial infarction (MI) and stroke in patients with either acute coronary syndromes (ACS) or stable coronary artery disease (CAD), and has been demonstrated to reduce all-cause mortality in patients with ACS. (SOR A, based on a meta-analysis.)en_US
dc.identifier.citationEvidence Based Practice 12(12): 07-08.en_US
dc.identifier.urihttp://hdl.handle.net/10355/7665
dc.publisherFamily Physicians Inquiries Networken_US
dc.relation.ispartofEvidence Based Practice 12(12): 07-08.en_US
dc.relation.ispartofcollectionEvidence Based Practice, 2009en_US
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network. Evidence Based Practice.en_US
dc.relation.ispartofseriesHelp Desk Answersen_US
dc.subjectcardiovascular eventen_US
dc.subjectlipoprotein concentrationen_US
dc.subject.lcshLipoproteinsen_US
dc.subject.lcshNon-insulin-dependent diabetesen_US
dc.subject.lcshCardiovascular emergenciesen_US
dc.titleWhat is the value of intensive statin therapy in lowering morbidity and mortality in patients at high risk for coronary artery disease?en_US
dc.typeArticleen_US


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record